MGUS: predicting the risk of progression
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2019-09-15
Просмотров: 3818
Описание: Tarek H Mouhieddine, MD, Dana-Farber Cancer Institute, Boston, MA, describes the rationale for the improved identification of high-risk patients who may be appropriate for novel clinical interventions to prevent progression or eradicate premalignant clones prior to the development of overt multiple myeloma (MM) at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: